Guardian Pharmacy Services (NYSE:GRDN) Receives “Buy” Rating from Truist Financial

Truist Financial restated their buy rating on shares of Guardian Pharmacy Services (NYSE:GRDN) in a research report released on Monday morning,Benzinga reports. Truist Financial currently has a $28.00 target price on the stock, up from their previous target price of $25.00.

Separately, Raymond James set a $28.00 price objective on Guardian Pharmacy Services and gave the stock an “outperform” rating in a research note on Wednesday, May 14th.

Guardian Pharmacy Services Stock Performance

Guardian Pharmacy Services stock opened at $26.42 on Monday. The stock’s fifty day moving average price is $22.88 and its two-hundred day moving average price is $21.90. Guardian Pharmacy Services has a one year low of $14.16 and a one year high of $26.91.

Guardian Pharmacy Services (NYSE:GRDN) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.01). The business had revenue of $329.31 million during the quarter, compared to analysts’ expectations of $321.21 million. As a group, equities research analysts forecast that Guardian Pharmacy Services will post 0.87 EPS for the current fiscal year.

Hedge Funds Weigh In On Guardian Pharmacy Services

Several hedge funds and other institutional investors have recently modified their holdings of GRDN. R Squared Ltd bought a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $30,000. Investment Research & Advisory Group Inc. bought a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $34,000. BNP Paribas Financial Markets bought a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $37,000. Compass Financial Services Inc bought a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $58,000. Finally, JPMorgan Chase & Co. bought a new position in shares of Guardian Pharmacy Services in the 4th quarter valued at $77,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.